Monitor for any future BVF filings that signal a shift in strategy or increased activism, as the departure of a BVF-affiliated director without replacement could indicate reduced board influence. The unchanged ownership and lack of new demands suggest a passive posture for now.
Price Chart
Executive Summary
Biotechnology Value Fund (BVF) filed an amended Schedule 13D reporting that Dr. Gorjan Hrustanovic resigned from Olema's board effective October 14, 2026, and also resigned from the Compensation and Science & Technology Committees. The resignation was not due to any disagreement. BVF's aggregate beneficial ownership remains at approximately 9.8% of shares outstanding, with no changes in stake or purpose. This filing reflects a routine board departure by a BVF-affiliated director, not an escalation or de-escalation of activist pressure.
Key Financial Metrics
Key Facts
- Dr. Gorjan Hrustanovic resigned from the board and its committees effective October 14, 2026, not due to any disagreement.
- BVF and related entities continue to beneficially own approximately 9.8% of Olema's outstanding shares (8,939,731 shares including pre-funded warrants).
- No transactions in Olema securities were reported by any reporting person in the past 60 days.
- BVF's stated purpose and demands remain unchanged from prior filings.
Financial Impact
No financial impact — the filing reports a routine board resignation with no change in ownership or activist demands.
Risk Factors
- Potential loss of activist board representation if BVF does not nominate a replacement director.
- No immediate catalyst — the filing is administrative and does not alter the investment thesis.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0000921895-26-002806 |
| Document: 0000921895-26-002806-index.html | 0000921895-26-002806 |
| Document: 0000921895-26-002806.txt | 0000921895-26-002806 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | SC 13D/A | $7.11 | awaiting T+20 | — | $6.59 (−7.31%) |
Oct 15, 2026 10d ago | 8-K | $6.58 | awaiting T+20 | — | $6.59 (+0.15%) |
Oct 2, 2026 23d ago | Press Release | $8.25 | awaiting T+20 | — | $6.59 (−20.12%) |
Aug 10, 2026 10w ago | 8-K | $10.43 $10.36 | ▼ −0.67% | ▲ +0.39% | $6.59 (−36.82%) |
Aug 10, 2026 10w ago | Press Release | $10.43 $10.36 | ▼ −0.67% | ▲ +0.39% | $6.59 (−36.82%) |
Aug 9, 2026 11w ago | Institutional Cluster | $11.94 $10.99 | ▲ +8.00% | ▲ +7.08% | $6.59 (+44.81%) |
May 26, 2026 21w ago | 8-K | $13.55 $11.46 | ▼ −15.42% | ▼ −13.48% | $6.59 (−51.37%) |
May 26, 2026 21w ago | Press Release | $13.55 $11.46 | ▼ −15.42% | ▼ −13.48% | $6.59 (−51.37%) |
May 21, 2026 22w ago | 8-K | $13.68 $10.19 | ▼ −25.51% | ▼ −24.10% | $6.59 (−51.83%) |
May 21, 2026 22w ago | Press Release | $13.68 $10.19 | ▼ −25.51% | ▼ −24.10% | $6.59 (−51.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers